Microcoat now offering Assay Development and Sample Measurement on MSD® Platform
Microcoat expands its technological portfolio by Meso Scale Discovery´s Electrochemiluminescence (MSD-ECL) platform. Based on non-radioactive electrochemiluminescent labels for ultra-sensitive detection, MSD yields higher sensitivity and broader dynamic range compared to ELISA technology. Microcoat offers development of assays from the scratch as well as transfer of classical ELISA formats in addition to method comparison, validation and sample measurement. Customers profit from our year-long experience in custom-fit optimization and manufacturing of antibody conjugates including MSD´s SULFO-Tag®.
MORE NEWS
- 05Jul
Microcoat announces the 2nd Monocyte-Activation Test Proficiency Test Program
Read More → - 04Jun
Microcoat adds Quanterix´s SP-X to its portfolio of ultra-sensitive Immunoassays
Read More → - 13Mai
Meet us at the A3P, Lyon (5. – 6. June 2019)
Read More → - 26Apr
Technical Report No. 82 „Low Endotoxin Recovery“
Read More → - 25Apr
Meet us at the Workshop „Bioindicators“, Barcelona (07. May 2019)
Read More → - 05Apr
Meet us at the Lonza Endotoxin Summit, (3. – 5. June 2019)
Read More → - 05Apr
Vortrag auf dem Concept Heidelberg Lehrgang aktuelle Trends bei Endotoxin- und Pyrogentests
Read More → - 26Mrz
Low Endotoxin Recovery – Masking of Naturally Occurring Endotoxin
Read More → - 22Jan
Meet us at the 14th Annual Biomarkers Congress 2019
Read More → - 06Dez
And the winner of the BOSE Headphones is…
Read More →
